Introduction {#Sec1}
============

Proper brain function depends on the precise arrangement of trillions of individual synaptic connections. While neurobiologists have been fascinated by the stereotyped complexity of neuronal networks for over a century, it is only in the last few decades that we have begun to understand some of the molecular mechanisms that govern the formation and function of these networks. The development of specific patterns of connectivity requires axons and dendrites of synaptic partners to be targeted to defined regions of the CNS, correctly identify their synaptic targets within that region, and then form specialised synapses with their targets. Each of these steps is mediated by a host of interactions between individual neurons and their targets. A defect at any stage of this process leads to incorrect patterns of connectivity and impaired nervous system function.

One of the first tasks a newly differentiated neuron must complete is to extend an axon towards its synaptic target(s). Axon guidance is thought to be mediated by extracellular cues which are expressed in concentration gradients that may exert either attractive or repulsive effects on incoming axons. Axons are able to navigate to their correct position by means of receptors expressed in the growth cone capable of responding to the various guidance cues. Once the axons have reached the appropriate regions, they need to correctly identify their targets amongst a heterogeneous population of cells. Combined expression of both synaptogenic (attractive) molecules and antisynaptogenic (repulsive) molecules in both presynaptic and postsynaptic cells is necessary to form the correct pattern of innervation. The final step in the formation of functional synaptic networks is the formation and specialisation of synapses. Two key molecules that have been implicated in this process are Neurexin and Neuroligin.

Neurexin and neuroligin are trans-synaptic binding partners expressed in the presynaptic and postsynaptic compartments respectively. As detailed below, both neuroligin and neurexin exhibit synaptogenic activity in cell culture assays \[[@CR1]--[@CR4]\]. Knockout studies in mice however, show that synaptogenesis is not significantly affected by loss of either and suggest that neuroligin may be more important for activity dependent maturation of synapses \[[@CR5]--[@CR7]\]. Given the apparent discrepancy between cell culture and knockout studies, it is important to first clearly define what is meant by synapse formation and maturation. For the purpose of this review, we will define a synapse as the sum of all connections between a presynaptic neuron and a postsynaptic target. As such, each synapse may consist of multiple morphologically distinct connections (e.g., synaptic boutons in a neuromuscular junction (NMJ)). Based on this definition of a synapse, synapse formation can be defined as the transient establishment of the first functional contact between the presynaptic neuron and its postsynaptic partner. The stabilisation of that contact through pre- and postsynaptic signalling cascades, or the creation of additional contacts between the pre- and postsynaptic cell then falls under the broader definition of synapse maturation.

Since early studies of neuroligin and neurexin function in cell culture used changes in the total number of synaptic specialisations as a readout of synaptogenesis, the results reflect a combination of both synaptogenesis and synaptic maturation. Furthermore, the two processes may be difficult to separate under such experimental conditions. Upon closer inspection, it was noted that the "synaptogenic" activity of neuroligins 1 and 2 is suppressed when synaptic activity is blocked \[[@CR5]\]. Based on these results, it was proposed that rather than mediating synaptogenesis, trans-synaptic interactions between neurexin and neuroligin may be more important for synapse maturation and specifically, activity dependent modification of synaptic strength \[[@CR8]\]. In the present review, we will discuss some recent observations made in invertebrates that lend support to this hypothesis.

Neurexin {#Sec2}
========

Neurexins were originally identified as presynaptic receptors for the black widow spider toxin α-latrotoxin \[[@CR9]\]. Three neurexin homologues have been identified in mammals, each of which gives rise to an α-neurexin and a β-neurexin via independent promoters \[[@CR10]\]. Homologues of α-neurexin have also been identified in several invertebrate species including *Drosophila*, *Caenorhabditis elegans*, honeybees and *Aplysia* \[[@CR10]--[@CR12]\]. Until recently, there was no evidence of β-neurexin isoforms in invertebrates suggesting that this may be a relatively recent evolution of the gene \[[@CR10], [@CR12]\]. However, a recent analysis of the neurexin superfamily of genes in *C. elegans* identified a β-neurexin splice form of the *nrx-1* gene \[[@CR13]\] suggesting that a closer analysis of other invertebrate neurexins may be required.

α-Neurexins and β-neurexins encode type I transmembrane proteins with identical intracellular domains but different extracellular domains \[[@CR9]\]. The short intracellular domain of neurexins binds to a number of presynaptic proteins such as synaptotagmin \[[@CR14]\], CASK \[[@CR15]\] and Mint \[[@CR16]\] via a postsynaptic density (PSD)-95/discs large/zona-occludens-1 (PDZ) binding motif at the C terminus. The extracellular domain of α-neurexin has a signal peptide at the N terminus, three epidermal growth factor like domains, each surrounded by two laminin/neurexin/sex hormone-binding globulin domains (LNS) and an O-linked carbohydrate-rich region proximal to the transmembrane domain \[[@CR9]\]. The extracellular domain of β-neurexin has a single LNS domain in addition to the O-linked carbohydrate-rich stalk \[[@CR9], [@CR17]\]. All three mammalian neurexins are capable of generating both an α-neurexin and a β-neurexin isoform. Furthermore, each α-neurexin has five canonical splice sites, two of which are also present in the β-neurexin isoforms. Alternative splicing at these sites allows for the generation of hundreds of alternative neurexin isoforms, each of which has unique binding affinities for different substrates \[[@CR18]--[@CR22]\].

All neurexins show broad, yet heterogeneous expression throughout the nervous system by in situ hybridization \[[@CR23], [@CR24]\]. Based on immunoflourescence analysis and known interactions between the intracellular domain of neurexin and several presynaptic proteins, neurexins are thought to exist primarily at presynaptic membranes \[[@CR12], [@CR13], [@CR25]--[@CR27]\]. However, neurexins have also been observed at the postsynaptic membrane in some synapses and have been shown to exert cell autonomous effects on postsynaptic receptor function \[[@CR12], [@CR26], [@CR28], [@CR29]\] suggesting that both the expression pattern and function of neurexins may be broader than originally hypothesised.

Neuroligins {#Sec3}
===========

Neuroligins were first identified as synaptic binding partners for neurexins \[[@CR30]\]. Four neuroligin homologues have been identified in mammals plus an additional neuroligin homologue on the Y chromosome in humans \[[@CR30]--[@CR33]\]. Homologues of neuroligin have also been identified in the nervous systems of many invertebrates including *Drosophila* (four homologues \[[@CR34], [@CR35]\]), *Aplysia* (single homologue \[[@CR12]\]), honeybees (five homologues \[[@CR11], [@CR36]\]) and *C. elegans* (single homologue \[[@CR37]\]). So far, only two of the four homologues in *Drosophila* have been functionally characterised \[[@CR34], [@CR35]\]. Neuroligins have been implicated in sensory modulation in both honeybees and *C. elegans* \[[@CR36], [@CR37]\], and in long-term synaptic modulation in *Aplysia* (discussed in more detail below \[[@CR12]\]). Phylogenetic analysis of neuroligin sequences from multiple species suggests that neuroligins diversified independently during evolution in both vertebrates and insects. By contrast, neurexins have diversified in vertebrates, but not in insects (Fig. [1](#Fig1){ref-type="fig"}). In addition to gene duplications giving rise to three neurexin genes in vertebrates, vertebrate neurexins have also acquired an alternative promoter and multiple splice sites that significantly increase the potential diversity of neurexin transcripts in vertebrates. The diversity of neuroligin genes across a wider range of species suggests that neuroligin may be under stronger evolutionary selection than neurexin.Fig. 1Neurexin and neuroligin structure, function and evolution. **A** Domain structure of *Drosophila* neuroligins and neurexin compared to human neuroligin 1 and neurexin 1-α. The conservation of individual protein domains between *Drosophila* homologues and the human gene are given as a % identity. The global conservation is listed to the right side of each homologue. **B** Phylogenetic tree of neuroligin sequences from multiple species. *Red branches* indicate neuroligin sequences in vertebrates, *blue branches* indicate neuroligin sequences in insects and *green branches* indicate neuroligin sequences in worms. This tree was adapted from tree TF326187 (available at <http://www.treefam.org>). As seen from this tree, neuroligin sequences diversified independently in insects and vertebrates from a common ancestral neuroligin sequence. Branches corresponding to the four neuroligin genes in vertebrates and the two characterised neuroligin genes in *Drosophila* are indicated. **C** Phylogenetic tree of neurexin sequences from multiple species. *Red branches* indicate neurexin sequences in vertebrates, *blue branches* indicate neurexin sequences in insects and *green branches* indicate neurexin sequences in worms. This tree was adapted from tree TF32103 (available at <http://www.treefam.org>). Neurexin sequences have shown less diversification in insects than vertebrates. Branches corresponding to the three neurexin genes in vertebrates and the *Drosophila dnrx* gene are indicated

Neuroligins encode type I transmembrane proteins composed of a long extracellular domain and a relatively short intracellular domain. The extracellular portion of neuroligin contains an O-linked carbohydrate-rich region near the transmembrane domain and a single globular domain with a high degree of sequence homology to acetylcholinesterases that lacks catalytic activity \[[@CR30]\]. The intracellular portion of neuroligin contains a PDZ binding motif at the extreme C-terminal end of the protein that has been show to interact with the PDZ domain scaffolding proteins PSD-95, Shank and Gephryn \[[@CR38]--[@CR40]\]. Like neurexin, neuroligin also contains alternative splice variants and the binding affinity of neuroligin for either α-neurexin or β-neurexin is greatly affected by alternative splicing \[[@CR20], [@CR30], [@CR33], [@CR41], [@CR42]\] suggesting that variable splicing of both neuroligin and neurexin may constitute a code governing the specificity of synaptic interactions.

While all neuroligins localise to postsynaptic densities, in mammals, different neuroligin homologues localise to different synapse classes. Neuroligins 1 and 2 localise exclusively to excitatory and inhibitory synapses respectively, while neuroligin 3 localises to both \[[@CR43]--[@CR45]\]. Neuroligin 4 has also recently been shown to localise to inhibitory synapses, preferentially with glycinergic synapses \[[@CR46]\]. The synapse specific localization of different neuroligin homologues may be regulated by interactions with postsynaptic scaffolding proteins such as PSD-95 and gephyrin \[[@CR47]--[@CR49]\]. These results suggest that recruitment of specific neuroligin homologues may direct the development of individual synapses towards either an excitatory or inhibitory fate.

Neurexin/Neuroligin Function and Synaptic Maturation {#Sec4}
====================================================

Neurexin and neuroligin are primarily expressed on presynaptic and postsynaptic membranes respectively, and are thought to form a trans-synaptic complex. It should be noted however, that both neurexins and neuroligins have been shown to interact with other cell adhesion molecules \[[@CR50]--[@CR54]\], which may contribute to the functional and morphological defects observed in loss of function mutants. The first hints of the functional significance of complexes between neurexin and neuroligin came from a study showing that expression of neuroligin in non-neuronal cells was sufficient to induce presynaptic specialisations in co-cultured neurons \[[@CR4]\]. The neuroligin induced clustering of vesicles could be blocked if cultures were incubated with a soluble β-neurexin suggesting that trans-synaptic interactions between neuroligin and β-neurexin were necessary for presynaptic specialisation \[[@CR4]\]. In similar experiments, expression of neurexin in non-neuronal cells induced postsynaptic specialisations in co-cultured neurons \[[@CR2], [@CR3]\].

It should be noted that the synaptic specialisations observed in these studies consisted of clustering of synaptic vesicles or postsynaptic receptors. If we define a synapse as the sum of all synaptic connections between a pre- and postsynaptic cell, then this increase in the number of synaptic specialisations may not reflect an increase in the number of synapses, but rather an increase in the strength of pre-existing synapses, or perhaps an increase both in the number and strength of synapses. To address this issue, Chubykin et al. \[[@CR5]\] asked whether neuroligins 1 and 2 functioned as synapse-inducing agents, independent of synaptic activity, or whether they acted downstream of synaptic signalling to modify the strength of existing synapses. They found that blocking synaptic activity reduced the "synaptogenic" activity of neuroligins 1 and 2, suggesting that they stabilise and/or strengthen existing synapses in an activity dependent manner.

Consistent with this, studies in knockout mice show that neurexins and neuroligins are important for synaptic function, but do not significantly affect the number of synapses. Deletion of all three α-neurexins in mice did not appreciably alter synaptic structure \[[@CR6]\], however, synaptic function was significantly impaired. Moreover, both excitatory and inhibitory transmitter release in the CNS and acetylcholine release at the neuromuscular junction were reduced in α-neurexin knockout mice \[[@CR6], [@CR55]--[@CR57]\]. These defects were attributed, in large part, to impaired function of N-type and P/Q-type voltage gated calcium channels in the neurexin knockout mice \[[@CR6], [@CR57]\]. A cell autonomous reduction in postsynaptic *N*-methyl-[d]{.smallcaps}-aspartate (NMDA) receptor but not α-amino-3-hydroxy-5-methyl-4-isoxyzolepropionic acid receptor function was also observed in α-neurexin knockout mice \[[@CR28]\]. Homeostatic regulation of transmitter release at neuromuscular junctions was also impaired in α-neurexin knockout mice \[[@CR56]\], consistent with a role for α-neurexins in activity dependent growth of synapses. Interestingly, the consequences associated with a loss of β-neurexin have yet to be determined. Furthermore, it is unclear from these neurexin knockout studies what percentage of α-neurexin function is mediated via a trans-synaptic interaction with neuroligin.

Similar phenotypes were observed in neuroligin knockout mice. Loss of neuroligins 1--3 had no effect on brain architecture or synapse formation but significantly impaired both excitatory and inhibitory transmitter release \[[@CR7]\]. Whereas individual α-neurexins appear to be partially redundant \[[@CR6], [@CR55]--[@CR57]\], deletion of either neuroligins 1 and 2 specifically impaired excitatory or inhibitory transmitter release respectively \[[@CR58]--[@CR60]\]. For a list of synaptic, behavioural and morphological phenotypes observed in mice lacking either neurexin or neuroligin, see Table [1](#Tab1){ref-type="table"}. Taken together, the studies in knockout mice showed that while neurexin and neuroligin are not essential for synapse formation they are required for proper synaptic function. Furthermore, these studies are consistent with a role for neurexin and neuroligin in synapse maturation or development.Table 1Summary of phenotypes observed in neurexin and neuroligin mutant mouse modelsGeneNature of mutationAnimal behaviourSynaptic physiologyOtherReferenceNeuroliginsNL1 deletionImpaired spatial memory and increased grooming (repetitive behaviour) Increased grooming behaviour rescued by NMDA co-agonistReduced NMDA receptor mediated currents and LTP in hippocampus. Reduced NMDA/AMPA receptor ratio in dorsal striatum30% increase in NL3 expression plus 20% decrease in α- and β-neurexin\[[@CR5], [@CR58]\]NL1 knockdownReduced associative fear memory, no change in anxiety levelsReduction in NMDA receptor mediated currents and LTP in amygdala\[[@CR61]\]NL2 deletionIncreased anxiety like behaviour and decreased pain sensitivity and motor coordinationInhibitory transmitter release reduced in cortical slices and the dentate gyrus, no effect on excitatory transmitter release. Also no effect on IPSC amplitude evoked from somatostatin positive neuronsDecrease in the density of inhibitory synaptic puncta in hippocampus. Decrease in number of postsynaptic GABA and Gephyrin clusters. No change in number of synapses, or density of excitatory puncta\[[@CR5], [@CR59], [@CR60], [@CR62], [@CR100]\]NL3 R451C substitutionDecrease in social interactions. Enhanced spatial learning and memory. No change in anxiety like behaviourIncrease in both spontaneous and evoked inhibitory release. No change in excitatory release∼90% decrease in NL3 in forebrain plus small increase in inhibitory synapse markers. Increased VGAT signal per synapse\[[@CR63]\]NL3 deletionNo significant changes in either inhibitory or excitatory neurotransmission in somatosensory cortexNo detectable changes in brain architecture or chemistry\[[@CR63]\]NL1-3 triple knockoutShallow breathingInhibitory transmission in the hypoglossal nucleus was reduced. Both excitatory and inhibitory transmission was reduced in the pre-Botzinger complex; Inhibitory transmission was more strongly affectedSynapse morphology was not significantly altered. There was a slight reduction in the staining of postsynaptic GABA receptors\[[@CR7]\]NeurexinsNRX-1αIncreased grooming and repetitive behaviour, impaired nest building and improved motor learning. No change in spatial learningReduced excitatory transmission at hippocampus, no change in inhibitory transmitter release\[[@CR55]\]α-NRX triple knockoutShallow breathingReduced spontaneous and evoked neurotransmission in CNS, due to reduced N-type calcium channel function. Reduced transmitter release at slow-twitch NMJsBrain and synapse structure normal. Small decrease in neuropil areas, due to reduced dendritic spines. Decrease in density of inhibitory synapses. Diaphragm NMJs less able to upregulate quantal content\[[@CR6], [@CR56], [@CR57], [@CR64]\]*NMDA N*-methyl-[d]{.smallcaps}-aspartate, *AMPA* α-amino-3-hydroxy-5-methyl-4-isoxyzolepropionic acid

Neurexin and Neuroligin Mediate Maturation of the NMJ in *Drosophila* {#Sec5}
=====================================================================

The highly stereotyped pattern of musculature and innervation in *Drosophila* embryos and larvae has made neuromuscular junction development in *Drosophila* an excellent model for studying all aspects of synapse formation. First, newly differentiated motorneurons send their axons into the periphery toward the target muscle fibres \[[@CR65]\]. Once at the body wall, each axon then selects the correct muscle(s) with which to synapse \[[@CR66], [@CR67]\]. Finally, as the embryos hatch and progress through larval development, the muscles increase significantly in size requiring substantial remodelling of the synapse in order to maintain the necessary strength of synaptic input \[[@CR68], [@CR69]\]. By studying the role of neurexin and neuroligin in this process, it should be possible to more accurately dissect at exactly which stages of synapse formation/maturation they are required. An additional advantage of this system is that it is possible to analyse the role of specific genes in synapse formation/maturation with single cell resolution in an in vivo context, something that is difficult to achieve in the mammalian CNS.

Several studies have examined the role of both neurexin and neuroligin in NMJ development in *Drosophila* \[[@CR26], [@CR27], [@CR34], [@CR35], [@CR70]\]. *Drosophila* has a single neurexin homologue and four neuroligin homologues. Recent studies have examined the role of *Drosophila* neurexin (*dnrx*) and two of the four *Drosophila* homologues of neuroligin (*dnl1* and *dnl2*) in NMJ formation and maturation \[[@CR26], [@CR27], [@CR34], [@CR35], [@CR70]\]. Interestingly, while there is some overlap in the mutant phenotypes of *dnrx*, *dnl1* and *dnl2,* there are also phenotypic traits unique to each gene suggesting independent roles for each at the same synapse \[[@CR26], [@CR27], [@CR34], [@CR35], [@CR70]\]. All three genes show strong expression at the NMJ, however, *dnl1* appears to be a muscle specific homologue \[[@CR34]\] while *dnl2* and *drnx* show strong nervous system expression in addition to muscle expression \[[@CR26], [@CR27], [@CR35], [@CR70]\]. Deletion of *dnl1, dnl2* or *dnrx* leads to a number of both presynaptic and postsynaptic defects.

Deletion of either *dnl1 or dnl2* or deletion of *dnrx* leads to a reduction in the number of synaptic boutons at larval NMJs \[[@CR26], [@CR27], [@CR34], [@CR35], [@CR70]\]. In the case of the *dnl1* mutants, this reduction in bouton number results from a failure of the NMJ to expand during development since embryonic NMJs were not significantly different \[[@CR34]\]. In wild-type animals, the number of synaptic boutons in larval NMJs increases in an activity dependent manner throughout larval development \[[@CR71]--[@CR73]\]. The reduced NMJ expansion in *dnl1* mutants is consistent with a role for neuroligin in synapse maturation. In contrast however, embryonic and larval NMJs are smaller than the control in *dnrx* mutants \[[@CR26], [@CR27]\] suggesting that *dnrx* may be involved in NMJ development at a much earlier stage than *dnl1*. Both *Drosophila* neuroligin mutants and the *dnrx* mutant also showed a defect in the number of active zones. In *dnl1* mutants, the total number of active zones was reduced, consistent with the decrease in synaptic boutons \[[@CR34]\]. By contrast, both the number and density of active zones per synaptic bouton were increased in *dnl2* and *dnrx* mutants (\[[@CR27], [@CR35]\], see Table [2](#Tab2){ref-type="table"} for a list of phenotypes observed in *Drosophila* neurexin and neuroligin mutants).Table 2Summary of phenotypes observed in Drosophila Neurexin and Neuroligin mutantsGeneNature of mutationAnimal BehaviourSynaptic PhysiologyOtherReferenceNeuroligin*dnl1* deletionNot testedDecreased stimulus evoked transmitter release, no change in quantal sizeDecrease in number of synaptic boutons, immature postsynaptic apparatus, misalignment of pre- and postsynaptic specialisation\[[@CR34]\]*dnl2* deletionReduced larval locomotionIncreased stimulus evoked transmitter release, decreased paired pulse plasticity, no change in quantal sizeDecrease in number of synaptic boutons, increased density of active zones per bouton, immature postsynaptic apparatus, decrease in GluR density, increase in ratio of A-type to B-type GluRs, increased length of PSD\[[@CR35]\]Neurexin*dnrx* deletionReduced larval locomotion, defect in associative learning in larvae, shortened life spanDecreased stimulus evoked transmitter release, decreased synaptic vesicle recycling, defective calcium sensitivity of evoked transmitter releaseReduced synapse number in CNS and at NMJ, increased density of active zones per bouton at NMJ, increased size of PSD, increase ratio of A-type to B-type GluR receptors in embryonic NMJs\[[@CR26], [@CR27], [@CR70], [@CR91]\]Neurexin--neuroligin double mutants*dnrx/dnl1*Not testedNot testedDefects in synaptic boutons no worse than in *dnl1* mutants, *dnl1*^D356R^ rescued phenotype in *dnl1* mutant background but does not show dominant negative phenotype like wild type when overexpressed\[[@CR34]\]*dnrx/dnl2*More severe defect in locomotion than either *dnl2* or *dnrx*Not testedLethal at late 2nd instar larval stage. More severe defect in NMJ morphology in both double homozygous early 2nd instar larvae, and hemizygous 3rd instar larvae. Dnl2 shown to exist in complex with Dnrx in vivo\[[@CR35]\]

In addition to the morphological defects, *dnl1*, *dnl2* and *dnrx* mutants also show defects in synaptic transmission at the NMJ \[[@CR27], [@CR34], [@CR35]\]. As with the defects in morphology however, the defects in synaptic function also differed between the various mutants. Both *dnl1* and *dnrx* mutants showed a reduction in evoked transmitter release \[[@CR27], [@CR34]\]. In the case of the *dnl1* mutants, this reduction in transmitter release is consistent with the reduction in the number of synaptic boutons and active zones. As such, the functional defects are likely a consequence of changes in synaptic morphology at *dnl1* mutant NMJs. By contrast, *dnl2* mutants showed an increase in transmitter release relative to controls \[[@CR35]\]. While *dnl2* mutants showed fewer synaptic boutons than controls, the number of active zones per bouton was increased \[[@CR35]\]. As such, changes in transmitter release in both *dnl1* and *dnl2* mutants are likely a reflection of changes in the number of active zones. In *dnl1* mutants, fewer active zones leads to a reduction in transmitter release, while in *dnl2* mutants, increased active zones translates to an increase in transmitter release.

The situation in *dnrx* mutants, however, is somewhat more complicated. *dnrx* mutants showed a reduction in the number of synaptic boutons, but an increase in the number of active zones per bouton, similar to that seen in *dnl2* mutants \[[@CR27], [@CR35]\]. However, unlike *dnl2* mutants, *dnrx* mutants showed a reduction in transmitter release. This discrepancy may be explained by an interaction between neurexin and voltage gated calcium channels. Neurexin knockout mice showed defects in synaptic transmission that were attributed, in large part, to impaired function of N-type and P/Q-type voltage gated calcium channels in the neurexin knockout mice \[[@CR6], [@CR57]\]. Given that *dnrx* mutant NMJs also showed defects in calcium sensitivity, which were not observed in *dnl2* mutants \[[@CR27], [@CR35]\], it seems likely that the functional differences between *dnl2* and *dnrx* mutant NMJs can be attributed to changes in calcium channel function.

The increase in the density of active zones observed in *dnl2* and *dnrx* mutants is particularly interesting since it has been suggested that each active zone requires a fixed perisynaptic area for proper function such that the density of active zones within synaptic boutons is homeostatically maintained at a constant level \[[@CR74]\]. However, an interesting exception to this rule was noted in animals that lack the *Drosophila* glutamate receptor (GluR) subunit GluR IIA \[[@CR75], [@CR76]\]. GluRs at the NMJ in *Drosophila* are formed by a heteromeric tetramer of five possible subunits. All GluRs contain the GluR IIE, GluR IID and GluR IIC (or GluR III) subunits \[[@CR77]--[@CR79]\]. In addition, each GluR also contains either a GluR IIA or GluR IIB subunit, and receptors containing these subunits are referred to as A-type or B-type, respectively \[[@CR78], [@CR80], [@CR81]\]. Immature PSDs are composed primarily of A-type receptors, then during maturation, the ratio of A-type to B-type receptors becomes more balanced \[[@CR82]\]. Interestingly, in both *dnl2* mutants and embryonic *dnrx* mutants, PSDs show an increased abundance of A-type receptors indicating that the PSDs in these mutants are immature \[[@CR26], [@CR35]\]. It is unclear at present whether a similar shift in the ratio of A-type to B-type receptors also exists in *dnl1* mutants.

Changes in the expression of the GluR IIA subunit (independently of changes in the other subunits) induce a retrograde signal that mediates changes in the number of presynaptic active zones \[[@CR75], [@CR76]\]. Over-expression of the GluR IIA subunit leads to an increase in the number of active zones but does not change the density of active zones within single synaptic boutons \[[@CR76]\]. Reductions in the expression of the GluR IIA subunit leads to a reduction in the number of synaptic boutons, with a compensatory increase in the density of active zones within the boutons \[[@CR75], [@CR76]\]. In contrast to these observations, *dnl2* and *dnrx* mutants show an increase in GluR IIA expression, yet the density of active zones is increased in these mutants \[[@CR26], [@CR35]\]. The mechanisms that link postsynaptic GluR IIA expression levels to presynaptic active zone numbers and/or density are unclear. The observations in *dnl2* and *dnrx* mutant NMJs however \[[@CR26], [@CR35]\], suggest that an interaction between neurexin and neuroligin may be involved in the link between GluR IIA expression and presynaptic active zone regulation (see below for further discussion).

Further evidence that neuroligin and neurexin regulate the coordination of presynaptic and postsynaptic architecture can be seen in the 'orphan' boutons observed in *dnl1* mutants \[[@CR34]\]. In *dnl1* mutants, a small percentage of synaptic boutons that contain the presynaptic release machinery, as visualised by the presence of synaptic vesicles, were observed to lack all postsynaptic markers, including GluR clusters \[[@CR34]\]. Similarly, long stretches of axon, devoid of any synaptic boutons were often observed in *dnrx* mutants, although it is unclear whether postsynaptic densities still existed under these axon branches \[[@CR27]\]. These misalignments between presynaptic and postsynaptic structures were also apparent at the ultrastructural level where the presynaptic membrane was sometimes observed to pull away from the postsynaptic membrane in both *dnl1* and *dnrx* mutants \[[@CR27], [@CR34]\]. In *dnl2* mutants however, no such misalignment between presynaptic and postsynaptic structures was observed.

Another interesting ultrastructural observation in these mutants was the change in the architecture of the postsynaptic membrane in *dnl1* and *dnl2* mutants. In the postsynaptic muscle cells, both *dnl1* and *dnl2* mutants showed a reduction in the complexity of the subsynaptic reticulum (SSR) \[[@CR34], [@CR35]\]. The SSR is composed of several layers of convoluted folds in the postsynaptic membrane surrounding type I boutons. Embryonic NMJs lack a SSR, and instead, synaptic boutons are closely apposed to the muscle membrane. As the muscles grow, simple folds start to appear in the muscle membrane beneath synaptic boutons, which become both more extensive and convoluted throughout larval development \[[@CR83]\]. The reduced complexity of the SSR in *dnl1* and *dnl2* mutants is indicative of an underdeveloped postsynaptic apparatus. Interestingly, mutations in *discs large* (*dlg*), the *Drosophila* homologue of PSD-95, also impairs the development of the SSR, similar to that seen in *dnl1* and *dnl2* mutants \[[@CR83], [@CR84]\]. Neuroligins are known to interact with PSD-95 in mammals through the C-terminal PDZ binding motif \[[@CR39]\]. While a direct interaction between *Drosophila* neuroligins and *dlg* has yet to be demonstrated, over-expression of *dnl1* in muscles leads to accumulation of *dlg* and a SSR under type II boutons, which normally lack these postsynaptic structures \[[@CR34]\]. This accumulation was not observed when *dnl1* constructs lacking the cytoplasmic domain (*dnl1*^∆cyto^) or the extracellular domain (*dnl1*^∆extra^) were expressed in muscles. Interestingly, the Dnl1^∆cyto^ construct was localised at type II terminals but still failed to recruit Dlg or a SSR. The Dnl1^∆extra^ construct did not localise to type II terminals, but rather, accumulated in granules that contained Dlg and GluRs \[[@CR34]\]. These observations suggest that Dnl1 may interact directly with Dlg and contribute to the formation of the SSR (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Model of known and potential interactions involving neurexin and neuroligin at the *Drosophila* neuromuscular junction. Dnl1 and Dnl2 are expressed in the postsynaptic muscle while Dnrx is expressed in the presynaptic neurons. Dnrx has also been shown to be present in the muscle during embyrogenisis. Based on their similarity to mammalian neuroligins, it seems likely that the *Drosophila* neuroligins form dimers, although this remains to be shown directly. Whether *Drosophila* neuroligins form exclusively as homodimers or as heterodimers (as shown for Dnl1/Dnl2) remains to be determined. Dnl2 forms a complex with Dnrx in vivo while the same has not been shown for Dnl1. Compelling evidence does exist however to suggest that *dnrx* complements *dnl1* function (see text for details). In the presynaptic terminal, Dnrx has been shown to interact with Caki, a *Drosophila* homologue of mammalian CASK. Mammalian neuroligins have been shown to interact with PSD-95 at excitatory synapses. Based on their similarity to mammalian neuroligins, we would predict that the *Drosophila* neuroligins may also interact with discs large (*Dlg*), the *Drosophila* homologue of PSD-95, although this remains to be shown experimentally. Dlg is known to bind to the homophilic cell adhesion molecule Fascicilin II (*FasII*) and regulate both presynaptic morphology and postsynaptic membrane organisation. Dlg also regulates the size of postsynaptic glutamate receptor (*GluR*) patches and the subunit composition of GluRs. As is the case for mammalian neurexins and neuroligins, both Dnrx and the *Drosophila* neuroligins are likely involved in many other interactions at the NMJ, but further work will be required to elucidate these interactions

Invertebrate Neurexin and Neuroligin Interactions {#Sec6}
=================================================

The observation of fewer synaptic boutons and immature postsynaptic architectures in *dnrx* and *dnl* mutants supports a role for neuroligin and neurexin in synaptic maturation. But can analysis of the *Drosophila* NMJ also offer insight into how these cell adhesion molecules might accomplish that? The presynaptic and postsynaptic enrichment of neurexin and neuroligin respectively, combined with cell culture assays that indicate a functional co-dependence suggests that these proteins form a trans-synaptic complex \[[@CR1]--[@CR4], [@CR40]\]. Indeed, structural analysis of neurexin--neuroligin interactions indicates that the extracellular domains of these proteins bind to each other in the presence of calcium \[[@CR20], [@CR22], [@CR85]--[@CR88]\]. Furthermore, the intracellular domains of both neurexin and neuroligin include PDZ binding motifs capable of binding to multiple PDZ domain proteins \[[@CR14]--[@CR16], [@CR38]--[@CR40]\]. Several interactions have been identified for both neurexin and neuroligin in mammals including synaptotagmin \[[@CR14]\], CASK \[[@CR15]\] and Mint \[[@CR16]\] for neurexin and PSD-95, S-SCAM, Shank and Gephryn \[[@CR38]--[@CR40]\] for neuroligin.

At the *Drosophila* NMJ, neurexin has been shown to directly interact with Caki, the *Drosophila* homologue of CASK \[[@CR70]\]. This interaction is mediated by the PDZ binding motif at the C-terminal end of neurexin. *caki* mutants show several defects in NMJ structure and function, similar to those observed in *dnrx* mutants. However, only some of the *dnrx* mutant phenotypes appear to be mediated via an interaction between *caki* and *dnrx.* For example, as discussed above, *dnrx* mutants have a reduced number of synaptic boutons \[[@CR26], [@CR27], [@CR70]\]. *caki* mutants, on the other hand show a small increase in the number of boutons \[[@CR70]\] suggesting that *caki* negatively regulates bouton numbers at the NMJ. Similar to *dnrx* mutants however, *caki* mutants show reduced transmitter release and vesicle recycling \[[@CR70]\]. Interestingly, animals that are trans-heterozygous for *caki* and *dnrx* show much more severe defects in synaptic function than animals that are heterozygous for either *caki* or *dnrx* alone \[[@CR70]\]. These results suggest that *caki* and *dnrx* act synergistically at the *Drosophila* NMJ to regulate synaptic function. In contrast, synaptic morphology was not affected in animals trans-heterozygous for *caki* and *dnrx*. This suggests that while synaptic function is regulated by an interaction between *caki* and *dnrx*, synaptic morphology is regulated independently by both genes. It is important to note that the enhancement of synaptic phenotypes observed in double heterozygous *caki/dnrx* mutants was not due to a change in the localization of either gene \[[@CR70]\]. In fact, contradictory to work performed in cultured hippocampal neurons \[[@CR89]\], synaptic localization of Dnrx does not require the PDZ binding motif at the C-terminal end \[[@CR70]\].

The cytoplasmic domain of Dnl1 is also important for the regulation of synapse maturation. Expression of a *dnl1* construct lacking the cytoplasmic domain (Dnl1^∆cyto^) in wild-type muscles produced NMJs that were even smaller than those observed in *dnl1* null mutants \[[@CR34]\]. Furthermore, in a *dnl1* mutant background, the Dnl1^∆cyto^ not only failed to rescue the NMJ mutant phenotype, but rather exacerbated it. In similar experiments, a *dnl1* construct lacking the extracellular domain (Dnl1^∆extra^) had no effect on NMJ morphology when expressed in a wild-type background, but also failed to rescue the defect in NMJ morphology in a *dnl1* mutant background \[[@CR34]\]. Both the Dnl1^∆extra^ and Dnl1^∆cyto^ constructs were expressed at type I NMJs, similar to wild-type Dnl1, however, the Dnl1^∆cyto^ construct was also apparent at type II terminals, whereas the Dnl1^∆extra^ construct was absent from these terminals \[[@CR34]\]. Rather, the Dnl1^∆extra^ construct accumulated in vesicles that also stained for Dlg and GluRs. These observations suggest that Dnl1 can be targeted to the correct synapses by either the extracellular or intracellular portions of the protein. However, ectopic accumulation of Dnl1 at type II terminals specifically requires the extracellular portion of Dnl1 \[[@CR34]\]. The localization of the truncated Dnl1 constructs at type I terminals may be facilitated by interactions with endogenous Dnl1 or Dnrx. At type II synapses however, where neither Dnl1 nor Dnrx are endogenously expressed at detectable levels, the extracellular domain Dnl1 appears to be required to facilitate the ectopic expression. Given that Dnrx has not been detected at type II terminals, this ectopic expression of Dnl1 may be mediated by trans-synaptic interactions with a different presynaptic protein, or alternatively, it may be mediated by an interaction with the extracellular domain of another postsynaptic protein (possibly one of the as yet uncharacterised *Drosophila* neuroligin genes).

The observation that expression of the Dnl1^∆cyto^ construct in wild-type muscles can induce a presynaptic defect in synaptic bouton morphology is particularly interesting. These results were interpreted as a dominant negative effect caused by the truncated Dnl1 construct being incorporated into signalling complexes, which were unable to propagate that signal to the muscle \[[@CR34]\]. Due to the postsynaptic localization of Dnl1, any effect of Dnl1 on presynaptic bouton morphology must involve a retrograde signal to the motorneuron. Assuming that the extracellular domain of the Dnl1^∆cyto^ construct is capable of the same interactions as wild-type Dnl1, the results indicate that binding between the extracellular domains of Dnl1 and Dnrx is not sufficient to induce a retrograde signal. However, postsynaptic signalling mediated through the cytosolic domain of Dnl1 does appear to be required for the retrograde signal. It is possible that the interaction between the extracellular domains of neurexin and neuroligin merely serves to align pre- and postsynaptic specialisations mediated by the intracellular domains of these proteins. It should be noted however that over-expression of the *dnl1*^∆cyto^ construct at NMJs may interfere with endogenous interactions between members of the cell adhesion machinery, thus preventing functional interactions. A recent study in cultured hippocampal neurons showed that the cytoplasmic region of neuroligin 3 is important in synapse maturation and that this effect is masked in the presence of endogenous neuroligin, presumably due to heterodimers formed between the truncated and endogenous proteins \[[@CR90]\]. It will be interesting to see how loss of both *dnl1* and *dnl2* affects NMJ formation and maturation in *Drosophila*.

Clues from Neurexin/Neuroligin Double Mutants {#Sec7}
=============================================

As discussed above, both the extracellular and cytoplasmic domains of neurexin and neuroligin play important roles in synapse maturation within the presynaptic and postsynaptic cells, respectively. One of the unique aspects of recent studies on neurexin and neuroligin function using the *Drosophila* NMJ as a model, is the in vivo examination of neurexin--neuroligin double mutants at the same synapse, which has not been examined in mammalian knockouts \[[@CR34], [@CR35]\]. Interestingly these studies suggest that the interaction between *dnrx* and either *dnl1* or *dnl2* are functionally different. The expression patterns of *dnl2* and *dnrx* showed substantial overlap both in the CNS and at synaptic boutons in the NMJ \[[@CR35]\]. By contrast, the expression of Dnl1 showed relatively little overlap with Dnrx, and appeared to concentrate in patches adjacent to Dnrx clusters \[[@CR34]\]. Consistent with the co-localization data, Dnl2 was shown to form a complex with Dnrx in vivo \[[@CR35]\] while the same could not be shown for Dnl1. It should be noted however, that Dnl1 may still functionally interact with Dnrx, and as detailed below, there are several lines of evidence to suggest a functional interaction between Dnl1 and Dnrx at the NMJ.

First, over-expression of untagged Dnl1 at high levels reduced the size of the NMJ, similar to that seen in *dnl1* or *dnrx* single mutants. This dominant negative effect however, was not observed in a *dnrx* mutant background or with a Dnl1 construct that lacks a residue predicted to be necessary for Dnrx binding \[[@CR34]\], suggesting that *dnrx* may contribute to the dominant negative effects of *dnl1* over-expression. Furthermore, postsynaptic Dnl1 clusters were reduced in size in *dnrx* mutants \[[@CR34]\] suggesting that Dnrx may facilitate the clustering of Dnl1. The morphological defects observed in *dnl1* mutants were considerably worse than those observed in either *dnrx* or *dnl2* mutants suggesting that *dnl1* may have a more fundamental role in regulating NMJ development. Loss of *dnrx* function in the *dnl1* mutant background did not significantly enhance the phenotype observed in *dnl1* mutants suggesting that *dnl1* may act through *dnrx* to regulate synaptic morphology. Interestingly however, the Dnl1mutant construct, which lacks a Dnrx binding site, was able to partially rescue synaptic morphology defects in *dnl1* mutants suggesting that *dnrx* is not absolutely required for *dnl1* function. Together, these data suggest that *dnrx* is not strictly necessary for *dnl1* function, but likely promotes *dnl1* function, possibly by concentrating Dnl1 at the NMJ \[[@CR34]\].

In contrast to *dnl1/dnrx* double mutants, which were completely viable and no worse than *dn1* mutants, *dnl2/dnrx* double mutants are lethal, (*dnrx* and *dnl2* single mutants are both viable \[[@CR35]\]). Furthermore, when NMJs from *dnrx/dnl2* double mutants were examined at an earlier developmental stage, prior to lethality, synaptic morphology defects were exacerbated in double mutants, compared to either single mutant \[[@CR35]\]. These results suggest that *dnrx* and *dnl2* may act in parallel pathways to regulate NMJ development.

Unlike mammals, *Drosophila* has only a single neurexin homologue \[[@CR27], [@CR91]\]. As such, it is possible that Dnl1 and Dnl2 compete with each other for Dnrx binding. Alternatively, Dnl1 and Dnl2 may co-operatively bind to Dnrx. Analysis of the structure of neuroligin/neurexin complexes revealed that neuroligin forms a constitutive dimer via the AChE-like domain. A single neurexin then binds to each neuroligin molecule, thus forming a trans-synaptic tetramer or double dimer \[[@CR85]\]. Furthermore, at synapses expressing multiple neuroligin homologues, neuroligin heterodimers can be formed between the different homologues \[[@CR43], [@CR90]\]. It is possible that Dnl1 and Dnl2 form a heterodimer, with Dnrx binding to both Dnl1 and Dnl2 (Fig. [2](#Fig2){ref-type="fig"}).

By comparing the synaptic phenotypes of *dnrx*, *dnl1* and *dnl2* mutants, it is apparent that all three genes play a role in maturation of the NMJ. However, despite the similarities in phenotypes, each mutant also shows some unique phenotypes suggesting that these genes may function independently of each other. So far, only two of the four neuroligin homologues in *Drosophila* have been characterised and it will be interesting to see what role (if any) the other homologues play at this synapse. Furthermore, it should also be noted that in mammals, both neurexin and neuroligin can mediate synaptic development via interactions with other cell adhesion molecules \[[@CR50], [@CR52], [@CR54]\]. Whether similar interactions regulate synaptic development in *Drosophila* remains to be determined.

Neurexins and Neuroligins in Autism Spectrum Disorder {#Sec8}
=====================================================

The studies detailed above demonstrate the importance of neurexin and neuroligin in activity dependent modulation of synapses. As such, it is not surprising that mutations in neurexin and neuroligin have been associated with developmental cognitive disorders such as autism spectrum disorders (ASD), Tourette syndrome and Schizophrenia \[[@CR8], [@CR92]\]. ASDs are characterised by behavioural abnormalities such as repetitive behaviours and/or restrictive interests and deficits in social interactions and communication \[[@CR93], [@CR94]\]. Genetic segregation studies in siblings and parents of children diagnosed with ASD combined with an approximately four fold higher prevalence in males suggests a strong genetic contribution to ASD \[[@CR94]--[@CR99]\]. Interestingly, many of the genes identified as potential risk factors for ASD are cell adhesion molecules including neurexin and neuroligin \[[@CR92]\].

Several studies in mice have attempted to model ASD symptoms through genetic manipulation of neuroligin or neurexin expression \[[@CR5], [@CR6], [@CR55]--[@CR64], [@CR100]\]. Consistent with the wide variation in symptoms and severity observed with ASD, the phenotypes in mice with different mutations are also quite varied. For example, mice lacking neuroligin 1 show impaired spatial memory and reduced LTP in the hippocampus \[[@CR58]\]. Furthermore, neuroligin 1 null mice were observed to spend more time grooming, which might reflect the increased repetitive behaviours observed in some autistic children \[[@CR58]\]. Interestingly, the abnormal grooming behaviour could be rescued by treating the mice with a NMDA receptor co-agonist suggesting that the behavioural defect was the result of reduced NMDA receptor activation. Mice lacking neuroligin 2 on the other hand show increased anxiety like behaviour and decreased pain sensitivity and motor coordination \[[@CR59]\]. Mice bearing a gain-of-function arginine to cysteine substitution (R451C) in the esterase homology domain show decreased social interaction and increased spatial learning, but do not show any change in anxiety like behaviour, such as those seen in neuroligin 2 knockout mice \[[@CR63]\]. Neurexin 1α knockout mice also show increased grooming behaviour, similar to that seen in neuroligin 2 knockouts \[[@CR55]\]. The variation in behavioural phenotypes observed in these different mutants is likely a reflection of differences in the physiological consequences of these mutations, which in turn reflects varied spatial and temporal requirements for the different homologues of each gene (For a list of both behavioural and physiological consequences of different neuroligin and neurexin mutations in vivo, see Table [1](#Tab1){ref-type="table"}).

Behavioural defects have also been observed in *Drosophila* neurexin and neuroligin mutants. Both *dnrx* and *dnl2* mutants show a reduction in locomotion compared with controls \[[@CR35]\]. While this defect may arise in part from the defects in NMJ structure and function described above, it is likely that defects in synaptic signalling within the CNS also contribute. Indeed, *dnrx* mutants showed a reduction in the number of synapses in the CNS \[[@CR91]\]. Interestingly *dnrx* mutant larvae also showed a reduction in associative learning that cannot be accounted for by the reduced locomotion \[[@CR91]\]. Studies in honey bees and *C. elegans* have suggested a link between neuroligin function and sensory processing \[[@CR36], [@CR37]\]. Neuroligin deficient *C. elegans* have defects in sensory processing \[[@CR37]\]. Furthermore, sensory deprivation in honey bees resulted in reduced neuroligin 1 expression while associative scent training resulted in increased expression of neurexin and neuroligins 1 and 3 \[[@CR36]\]. Unlike honeybees and worms however, the defect in olfactory associative learning in *dnrx* mutants was not due to changes in the olfactory preferences \[[@CR91]\]. The defect in associative learning in *dnrx* mutants likely represents an inability to modulate synaptic strength following training. Interestingly, the changes in neuroligin expression in honeybees were also interpreted to be the result of changes in neuronal wiring triggered by the altered sensory environment \[[@CR36]\].

Neurexin and neuroligin have also been implicated in the storage of long-term memory in *Aplysia* \[[@CR12]\]. In *Aplysia*, a monosynaptic connection between a siphon sensory neuron and the gill motor neuron is a crucial part of the gill withdrawal reflex which constitutes a learned fear behaviour. Repeated application of serotonin increases synaptic strength at this synapse and leads to a sensitization of the gill withdrawal behaviour \[[@CR101], [@CR102]\]. Long-term increases in synaptic strength are dependent not only on RNA and protein synthesis, but also on kinesin heavy chain (KHC) regulated anterograde transport \[[@CR103], [@CR104]\]. Interestingly, both neurexin and neuroligin were shown to be carried as cargo by the KHC complex during serotonin induced synaptic facilitation \[[@CR104]\]. It is not surprising then, that over-expression of both neurexin and neuroligin at this synapse leads to a long-term facilitation in the absence of serotonin treatment. Furthermore, depletion of either neuroligin in the motor neuron, or neurexin in the siphon sensory neuron decreased the long-term strengthening of this synapse following serotonin application \[[@CR12]\]. These observations in *Aplysia* are consistent with a trans-synaptic interaction between neurexin and neuroligin being crucial for activity dependent modulation of synaptic strength. It will be interesting to see whether *Drosophila* neuroligin mutants have cognitive defects that may be used to model ASD. Associative learning assays have been well characterised in *Drosophila* \[[@CR105]\] and learning defects have already been observed in *dnrx* mutants \[[@CR91]\]. Whether neuroligin mutants also have defects in learning and/or memory remains to be determined. In addition to learning assays however, assays for social behaviours are also possible in *Drosophila* \[[@CR106]\]. It will be interesting to see whether neuroligin or neurexin mutants in *Drosophila* display any defects in these social behaviours.

Conclusions {#Sec9}
===========

Our understanding of the roles of neurexin and neuroligin has evolved significantly over the last decade. From early hypotheses predicting a role in synapse formation, it is now generally accepted that a trans-synaptic interaction between these cell adhesion molecules is more important for activity dependent modulation of synaptic strength. There are however, many questions left to be answered regarding the roles of these proteins. For example, what role do β-neurexins play in synapse formation/maturation? Several studies have examined the role of α-neurexins \[[@CR6], [@CR55]--[@CR57], [@CR64]\], yet so far, there are no data on the role of β-neurexins. What are the functional consequences of the numerous splice forms of both neurexin and neuroligin? While the binding efficiency of different splice forms has been studied \[[@CR18], [@CR19], [@CR41], [@CR107]\], it is still unclear how the expression of different splice forms is regulated in vivo, and further, how interactions between specific splice forms affects downstream signalling. Another question that remains to be answered is what other binding partners are important for neuroligin and neurexin function? Recent work has indicated that both proteins can mediate trans-synaptic specialisation independently of each other \[[@CR52], [@CR54], [@CR108], [@CR109]\] and it has also been shown that neuroligin works co-operatively with the cell adhesion molecule N-cadherin \[[@CR50], [@CR110]\]. It is possible that neuroligin/neurexin may also work with or against other cell adhesion molecules to refine synaptic structure and function.

These are just some of the questions that remain to be answered in order to fully understand the complexity of synapse formation, maturation and modulation. The work reviewed here shows that the function of neuroligin and neurexin is evolutionarily conserved from *Aplysia* and *C. elegans*, all the way through to mammals. The ability to analyse synaptic development and modulation with single cell resolution in these model organisms will help in answering these and other questions in the future.
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